Patents Assigned to Healagenics, Inc.
  • Patent number: 7323184
    Abstract: The present invention relates to methods and compositions for inhibiting scar formation on wound region. In certain embodiments, the methods include administering an alkalinization agent in combination with hyaluronic acid to a wound site to reduce the formation of scars at the wound site. Suitable alkalization agents include sodium bicarbonate, sodium hydroxide and potassium hydroxide.
    Type: Grant
    Filed: June 28, 2006
    Date of Patent: January 29, 2008
    Assignee: Healagenics, Inc.
    Inventors: Mary Ellen Freddo, Ki Chang Keum, Naechoon Yoo, Won Min Yoo
  • Patent number: 7255883
    Abstract: The present invention relates to an agent for reducing scar formation, which inhibits the scar formation by injecting sodium bicarbonate to the dermis tissue of the wound with a syringe to directly control pH of the wound site, namely, by alkalinizing the wound to inactivate TGF-?. According to the present invention, the agent for reducing scar formation by controlling the wound healing process can be clinically and immediately applied to the treatment of tylosis scar and keloid, etc., and is effective to the treatment of intractable fibrosis diseases. Also, the invention can be widely applied in many ways as an easy tool which can control the action of TGF-? in a living organism.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: August 14, 2007
    Assignee: Healagenics, Inc.
    Inventors: Ki Chang Keum, Naechoon Yoo, Won-min Yoo